1. Home
  2. MRKR vs BMR Comparison

MRKR vs BMR Comparison

Compare MRKR & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.21

Market Cap

22.5M

Sector

Health Care

ML Signal

HOLD

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

HOLD

Current Price

$1.27

Market Cap

25.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRKR
BMR
Founded
1999
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
22.5M
25.2M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
MRKR
BMR
Price
$1.21
$1.27
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
62.4K
69.6K
Earning Date
05-14-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
33.61
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.20
Revenue Next Year
$936.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$1.06
52 Week High
$2.46
$3.75

Technical Indicators

Market Signals
Indicator
MRKR
BMR
Relative Strength Index (RSI) 33.81 40.90
Support Level $1.17 $1.06
Resistance Level $1.52 $1.98
Average True Range (ATR) 0.07 0.10
MACD -0.03 0.00
Stochastic Oscillator 1.76 45.43

Price Performance

Historical Comparison
MRKR
BMR

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

Share on Social Networks: